DIA401.02+0.04 0.01%
SPX5,525.21+40.44 0.74%
IXIC17,382.94+216.90 1.26%

Materialise Full Year 2024 Earnings: EPS: €0.23 (vs €0.11 in FY 2023)

Simply Wall St·04/24/2025 18:46:07
Listen to the news

Materialise (NASDAQ:MTLS) Full Year 2024 Results

Key Financial Results

  • Revenue: €266.8m (up 4.2% from FY 2023).
  • Net income: €13.4m (up 100% from FY 2023).
  • Profit margin: 5.0% (up from 2.6% in FY 2023). The increase in margin was driven by higher revenue.
  • EPS: €0.23 (up from €0.11 in FY 2023).
Our free stock report includes 1 warning sign investors should be aware of before investing in Materialise. Read for free now.
revenue-and-expenses-breakdown
NasdaqGS:MTLS Revenue and Expenses Breakdown April 24th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Materialise Earnings Insights

The primary driver behind last 12 months revenue was the Materialise Medical segment contributing a total revenue of €116.4m (44% of total revenue). The largest operating expense was Sales & Marketing costs, amounting to €61.6m (44% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of €3.98m. Explore how MTLS's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in the US.

Performance of the American Software industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Materialise that you should be aware of.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.